Ignite Creation Date:
2024-05-06 @ 1:01 PM
Last Modification Date:
2024-10-26 @ 1:08 PM
Study NCT ID:
NCT03914170
Status:
COMPLETED
Last Update Posted:
2023-09-26
First Post:
2019-04-11
Brief Title:
Folfirinox Cetuximab Chemotherapy in First Line With Wild RAS and According to BRAF Status in Metastatic Colorectal Cancer
Sponsor:
Institut du Cancer de Montpellier - Val dAurelle
Organization:
Institut du Cancer de Montpellier - Val dAurelle
Organization Data
Organization:
Institut du Cancer de Montpellier - Val dAurelle
Class:
OTHER
Study ID:
ICM-URC201631
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Institut du Cancer de Montpellier - Val dAurelle
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Merck Serono International SA | INDUSTRY |